Rising Pharmaceuticals, Inc. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Jan 28, 2019
  • No warning letters matched by name
Inspections 3 0 OAI
Recalls 9 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Rising Pharmaceuticals, Inc. has 9 FDA recalls, 3 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Rising Pharmaceuticals, Inc." is on file.

What these totals cover: FDA records filed under the name "Rising Pharmaceuticals, Inc." and its spelling variant "Rising Pharmaceuticals".

Latest recall
D-0348-2023 · Class II · Feb 15, 2023
Latest inspection
Jan 28, 2019 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls9Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections3Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Rising Pharmaceuticals, Inc.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Rising Pharmaceuticals, Inc.: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 2 inspections (0 OAI), 0 warning letters, 6 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500000
202400000
202300010
202200010
202100010
202000000
201920060
201800000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Rising Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Rising Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

9 recall records from Mar 7, 2019 to Feb 15, 2023.

NumberClassProductDate
D-0348-2023Class IIWarfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC…Feb 15, 2023
D-0573-2022Class IIMethylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for…Feb 7, 2022
D-0005-2022Class IIMeclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma…Sep 2, 2021
D-1368-2020Class IIITimolol Maleate Sterile Opthalmic Solution,USP 0.25%, 5 mL, Rx Only, For Topical Application…Nov 15, 2019
D-1367-2020Class IIITimolol Maleate USP, 0.5%, 5 mL, Sterile Opthalmic Solution, Rx Only, For Topical Application in…Nov 15, 2019
D-1054-2019Class IIValsartan Tablets 160 mg USP, 90 tablet bottles, Rx only, Distributed by: Acetris Health, LLC…Mar 7, 2019
D-1055-2019Class IIValsartan Tablets 320 mg USP, 90 tablet bottles, Distributed by: Acetris Health, LLC, Saddle Brook…Mar 7, 2019
D-1052-2019Class IIValsartan Tablets 40 mg USP, 30 tablet bottles, Rx, Only, Distributed by: Acetris Health, LLC…Mar 7, 2019
D-1053-2019Class IIValsartan Tablets 80 mg USP, 90 tablet bottles, Rx only, Distributed by: Acetris Health, LLC…Mar 7, 2019

Recent FDA inspections

3 inspections from Sep 16, 2013 to Jan 28, 2019.

DateSiteProductClassificationFEI
Jan 28, 2019Saddle Brook, NJDrugsVoluntary Action Indicated (VAI)3004813192
Jan 16, 2019Saddle Brook, NJFood/CosmeticsNo Action Indicated (NAI)3004813192
Sep 16, 2013Saddle Brook, NJDrugsNo Action Indicated (NAI)3004813192
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3004813192Saddle Brook, NJ3Jan 28, 2019

Rising Pharmaceuticals, Inc. and the FDA: common questions

Has Rising Pharmaceuticals, Inc. received an FDA warning letter?

No FDA warning letter addressed to the name "Rising Pharmaceuticals, Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Rising Pharmaceuticals, Inc. received an FDA Form 483?

FDA has not published a Form 483 for "Rising Pharmaceuticals, Inc." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Rising Pharmaceuticals, Inc.?

The most recent FDA inspection on file ended Jan 28, 2019 at Saddle Brook, NJ and was classified VAI. FDA has 3 inspections of Rising Pharmaceuticals, Inc. on file.

Has Rising Pharmaceuticals, Inc. had an FDA recall?

Yes. Rising Pharmaceuticals, Inc. has 9 FDA recalls on record. The most recent started Feb 15, 2023.

Need more than this page shows? Ask about Rising Pharmaceuticals, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.